Institute for Environmental Decisions, ETH Zurich, Zurich, Switzerland.
Environ Health. 2013 Jun 5;12:45. doi: 10.1186/1476-069X-12-45.
There is increasing concern that pollution from pharmaceuticals used in human medicine and agriculture can be a threat to the environment. Little is known, however, if people are aware that pharmaceuticals may have a detrimental influence on the environment. The present study examines people's risk perception and choices in regard to environmental risks of pharmaceuticals used in human medicine and for agricultural purposes.
A representative sample of the U.S. population (N = 640) was surveyed. Respondents completed a hypothetical choice task that involved tradeoffs between human and environmental health. In addition, it was examined how much people would support an environment policy related to drug regulation.
For agricultural pharmaceuticals, respondents reported a high level of satisfaction for a policy requiring farms to limit their use of antibiotics. In the domain of pharmaceuticals used in human medicine, we found that people were willing to consider environmental consequences when choosing a drug, but only when choices were made about treatment options for a rather harmless disease. In contrast, when decisions were made about treatment options for a severe disease, the drug's effectiveness was the most important criterion.
It can be concluded that the environmental impact of a drug will be hardly considered in decisions about pharmaceuticals for severe diseases like cancer, and this may be due to the fact that these decisions are predominantly affective in nature. However, for less severe health risks, people are willing to balance health and environmental considerations.
人们越来越担心,用于人类医学和农业的药品污染可能对环境构成威胁。然而,人们是否意识到药品可能对环境产生不利影响,目前还知之甚少。本研究考察了人们对人类医学和农业用途的药品的环境风险的风险感知和选择。
对美国代表性人群(N=640)进行了调查。受访者完成了一项假设性的选择任务,涉及人类健康和环境健康之间的权衡。此外,还研究了人们对与药物监管相关的环境政策的支持程度。
对于农业用药品,受访者报告说,要求农场限制抗生素使用的政策得到了高度认可。在人类医学用药品领域,我们发现人们在选择药物时愿意考虑环境后果,但只有在选择治疗相对无害疾病的治疗方案时才会这样做。相比之下,当涉及治疗严重疾病的治疗方案时,药物的有效性是最重要的标准。
可以得出结论,在治疗癌症等严重疾病的药物决策中,药物的环境影响几乎不会被考虑在内,这可能是因为这些决策主要是情感性质的。然而,对于不太严重的健康风险,人们愿意在健康和环境考虑之间进行权衡。